NCT06226948Completed
Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases
Source: ClinicalTrials.gov · Last updated 24 Jan 2025
Brief summary (registry, in English)
In the framework of PhD research, the investigators will present a visualization of estimation of CVDs risk and the possibility of monitoring blood glucose levels in real-time. Based on the results, the investigators will assess the association of these with lifestyle change. The findings highlight the need for sufficiently reliable and high-quality evaluations of visualizations, technologies or applications used in the family medicine.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 120 (actual)
- First submitted
- 17 Jan 2024
- Start date
- 6 May 2024
- Primary completion date
- 6 Dec 2024
- Lead sponsor
- University Maribor
- Diseases
- Coronary artery disease
- NCT number
- NCT06226948
What you commit to
- Study type: Interventional
- Participants enrolled: 120
- From 6 May 2024 to the primary completion date, 6 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- with serious disease progression
Age
- individuals younger than 40 years
Other
- without risk factor for CVDs
Who the study is looking for
- individuals ages more than 40 years
- without serious disease progression
- at least one risk factor for CVDs
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Health Sciences Coordinator of this site? Confirm its status | Maribor | Slovenia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.